These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37881888)

  • 1. Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines.
    Meloni M; Sana I; Mantione ME; Riba M; Muzio M
    FEBS Open Bio; 2023 Dec; 13(12):2367-2374. PubMed ID: 37881888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
    Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells.
    Fonte E; Vilia MG; Reverberi D; Sana I; Scarfò L; Ranghetti P; Orfanelli U; Cenci S; Cutrona G; Ghia P; Muzio M
    Haematologica; 2017 Nov; 102(11):1901-1912. PubMed ID: 28775123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
    Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells.
    Grandjenette C; Kennel A; Faure GC; Béné MC; Feugier P
    Haematologica; 2007 Sep; 92(9):1279-81. PubMed ID: 17768129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors.
    Fonte E; Apollonio B; Scarfò L; Ranghetti P; Fazi C; Ghia P; Caligaris-Cappio F; Muzio M
    Clin Cancer Res; 2013 Jan; 19(2):367-79. PubMed ID: 23224401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor-associated kinase 4 inhibitor interrupts toll-like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis.
    Delvecchio VS; Sana I; Mantione ME; Vilia MG; Ranghetti P; Rovida A; Angelillo P; Scarfò L; Ghia P; Muzio M
    Br J Haematol; 2020 May; 189(3):475-488. PubMed ID: 32057093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
    Hammadi A; Billard C; Faussat AM; Kolb JP
    Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
    Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
    J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.
    Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R
    Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.
    Stacchini A; Aragno M; Vallario A; Alfarano A; Circosta P; Gottardi D; Faldella A; Rege-Cambrin G; Thunberg U; Nilsson K; Caligaris-Cappio F
    Leuk Res; 1999 Feb; 23(2):127-36. PubMed ID: 10071128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
    Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
    Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
    Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
    Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
    Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
    Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
    Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia.
    Sana I; Mantione ME; Meloni M; Riba M; Ranghetti P; Scarfò L; Ghia P; Muzio M
    Eur J Immunol; 2023 Oct; 53(10):e2350418. PubMed ID: 37561992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli.
    Martinelli S; Maffei R; Fiorcari S; Quadrelli C; Zucchini P; Benatti S; Potenza L; Luppi M; Marasca R
    Leuk Res; 2017 Mar; 54():17-24. PubMed ID: 28092772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.